We’ve helped dynamic scientific and business thinkers turn ground-breaking ideas into profitable companies and reap the rewards of their innovation. Since 2000, 3i-backed entrepreneurs have achieved over 60 listings on 10 international exchanges and taken part in more than 100 trade sales, often for multi-million dollar sums.
In their own words, entrepreneurs and 3i investors tell the stories of a handful of our most successful partnerships.
Arakis (UK) - an emerging pharmaceutical company with a focus on inflammatory diseases.
“We wanted to work with a venture capital firm that was big enough to take a significant share of the investment and support us going forward. 3i was the perfect fit because it understands the biotechnology industry and has the deep pockets to support future rounds of funding.” Ken Cunningham, CEO.
Pharmetrics(USA) - providers of medical claims data to the US pharmaceutical industry.
“At the time we invested in Pharmetrics, a lot of potential investors just couldn’t see that selling medical claims data would turn out to be big business. But we knew that the company was on to something and helped them grow their idea into a money-making product for pharmaceutical giants. Once Pharmetrics was established as the only private operator in a highly-prized field, it became a natural acquisition for IMS, the global leader in pharmaceutical market intelligence.” Marko Maschek, 3i investor.
CSR (UK) - a world pioneer in Bluetooth wireless devices.
“As soon as you met the management team at CSR, you knew they had exactly the right ingredients: scientific genius, allied to powerful ambition. This was clearly a team that was hungry for success on a big scale. Our role was to do everything we could to help them grow - introducing contacts, sourcing talent, helping with contract negotiation. In the end, their customer list was like a ‘who’s who’ of global electronics giants. It was no surprise when they became this century’s first billion-dollar company in the fabless semiconductor market.” Laurence Garrett, 3i investor.
